Cardiovascular effects of breast cancer radiotherapy

• Published in: Cancer treatment reviews 2007-10, Vol.33 (6), p.578-593
• Main Authors: Senkus-Konefka, Elżbieta, Jassem, Jacek
• Format: Article
• Language: English
• Subjects: Breast cancer; Breast Neoplasms - radiotherapy; Breast Neoplasms - surgery; Cardiovascular complications; Cardiovascular Diseases - etiology; Hematology, Oncology and Palliative Medicine; Humans; Radiation Injuries - etiology; Radiotherapy
• ISSN: 0305-7372; 1532-1967
• DOI: 10.1016/j.ctrv.2007.07.011

Summary Cardiac toxicity has been implicated as the primary reason for excess non-breast cancer mortality in early breast cancer radiotherapy studies. Refinements in radiotherapy techniques have allowed for a considerable reduction of this risk in the majority of breast cancer patients. Recent large population-based studies confirmed an increase of cardiovascular death risk in patients irradiated for cancer of the left breast and in individuals exposed to relatively low (hitherto believed to be of no cardiovascular disease risk) doses of radiation, such as atomic bomb survivors or patients treated for various benign conditions. The issue of potential radiation-related cardiac damage may also be assuming a new significance due to the widespread use of other cardiotoxic agents, such as anthracyclines, paclitaxel and trastuzumab. The aim of this review is to summarize and critically analyze the available evidence on the impact of ionizing radiation on the cardiovascular system, with special attention to recent data demonstrating previously unrecognized adverse effects. This review discusses the pathology of radiation-related cardiovascular disease, its clinical presentation, risk factors and methods of assessment, as well as technical developments minimizing cardiac exposure. Epidemiological data are presented on the incidence of radiation-induced heart disease and cardiovascular mortality in various populations of patients irradiated for breast cancer and in individuals exposed to low radiation doses. Additionally, non-cardiac radiation-related vascular morbidity and mortality in breast cancer patients are addressed.